Veeda Group has introduced a new logo and brand identity—Veeda Lifesciences—marking its transformation from a generics-centric Contract Research Organization (CRO) to a comprehensive drug development services provider catering to various drug modalities, including generics as well as novel chemical and biological entities.
Veeda Lifesciences will function through four Strategic Business Units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and Preclinical & Non-Clinical Testing Services, positioning Veeda as a fully integrated research service provider.
This new identity signifies a shift from generics to innovation, local to global reach, and small molecules to biologics. Veeda Lifesciences is evolving towards a CRO-CDMO model, utilizing AI and real-world data to enhance its offerings.
Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Lifesciences, stated: “The name – Veeda Lifesciences – along with the newly designed modern and dynamic logo, represents the Group’s progressive mindset and commitment to its core values and mission. It embodies our aspirations for growth and our vision for the future, focusing on innovation, excellence, and client satisfaction.”
Established in India in 2004, Veeda Lifesciences now operates in five countries and conducts trials across 26 regions. The company provides a wide array of services to the life sciences and healthcare sectors, collaborating with esteemed sponsors, including leading global pharmaceutical firms.